Provided by Tiger Trade Technology Pte. Ltd.

Aptevo Therapeutics

2.44
+0.07503.17%
Volume:29.79K
Turnover:72.14K
Market Cap:4.40M
PE:-0.04
High:2.45
Open:2.35
Low:2.35
Close:2.37
52wk High:48.78
52wk Low:2.30
Shares:1.80M
Float Shares:1.65M
Volume Ratio:0.44
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-58.0829
EPS(LYR):-82.2951
ROE:-420.34%
ROA:-111.49%
PB:0.73
PE(LYR):-0.03

Loading ...

Aptevo Therapeutics Announces Special Shareholder Meeting

Reuters
·
13 hours ago

Aptevo Therapeutics files to sell 6.44M shares of common stock for holders

TIPRANKS
·
Aug 22

Aptevo Therapeutics Held Annual Shareholder Meeting

Reuters
·
Aug 22

Analysts Offer Insights on Healthcare Companies: Aptevo Therapeutics (APVO) and Jasper Therapeutics (JSPR)

TIPRANKS
·
Aug 18

Aptevo Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Aptevo Therapeutics Q2 EPS $(5.31) Beats $(6.16) Estimate

Benzinga Earnings
·
Aug 14

Aptevo Net Loss Widens to $13.1 Million in FY26 H1; Operating Cash Outflow Narrows to $13.4 Million

Reuters
·
Aug 14

Aptevo Wins $1.5 Million CARE Fund Grant for Apvo451 IND-Enabling Work

Reuters
·
Aug 14

Aptevo Names Mary Janatpour Chief Scientific Officer

Reuters
·
Aug 14

Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing

TIPRANKS
·
Aug 14

Aptevo Therapeutics Says Holders Exercise Existing Warrants for 254,922 Shares at USD 4.03 Each

Reuters
·
Aug 14

Aptevo Therapeutics Says Warrant Holders Exercise for Cash at USD 4.03 Per Share

Reuters
·
Aug 12

Aptevo Therapeutics Inc Expected to Post a Loss of $6.01 a Share - Earnings Preview

Reuters
·
Aug 07

Aptevo Therapeutics Announces Annual Shareholder Meeting

Reuters
·
Aug 01

Aptevo Therapeutics - Announces New Solid Tumor Strategy - SEC Filing

THOMSON REUTERS
·
Jul 28

Aptevo Therapeutics - Files Patent Application for Nectin-4 X Pd-L1 Dual-Targeting Backbone - SEC Filing

THOMSON REUTERS
·
Jul 28

Aptevo Files Patent for Nectin-4 X PD-L1 Dual-targeting Backbone for Solid Tumor Therapies

Reuters
·
Jul 27

Aptevo Therapeutics Secures Grant for APVO451 Development

TIPRANKS
·
Jul 01

Aptevo Therapeutics - Enters Grant Award Agreement with Andy Hill Care Fund - SEC Filing

THOMSON REUTERS
·
Jul 01

Aptevo Therapeutics - Care Fund to Provide $1.5 Mln Funding for Apvo451 Ind-enabling Studies - SEC Filing

THOMSON REUTERS
·
Jul 01